Skip to content
Tablet Allopathic

Ajuben 12 mg tablet

Generic: Deutetrabenazine

Company: Incepta Pharmaceuticals Ltd.. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength12 mg
PackStrip: 1300.00 taka

Reviewed by: not listed yet. Source: not listed yet.

Last updated August 30, 2025.

Compare

Same generic, same strength

Sorted by price per tablet. Ask your pharmacist before you switch brands.

Deutetrabenazine 12 mg tablets

Prices as listed on BestinMeds.

1 brand listed
Ajuben (this medicine)130.00 taka per tablet

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Deutetrabenazine guide

Indications

Deutetrabenazine is a vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the treatment of- Chorea associated with Huntington's disease Tardive dyskinesia in adults.

Dosage and administration

Patients not presently receiving Tetrabenazine: Chorea associated with Huntington’s disease- Initial dose: 6 mg/day Maintenance dose: 6 mg-48 mg/day Maximum dose: 48 mg/day Tardive dyskinesia- Initial dose: 12 mg/day Maintenance dose: 12 mg-48 mg/day Maximum dose: 48 mg/day Titrate up at weekly intervals by 6 mg per day to a tolerated dose that reduces chorea, up to a maximum recommended daily dosage of 48 mg (24 mg twice daily). Administer total daily dosages of 12 mg or above in two divided doses and administer with foods. Patients receiving Tetrabenazine: If switching patients from tetrabenazine, discontinue tetrabenazine and initiate deutetrabenazine the following day. The recommended initial dosing regimen of deutetrabenazine in patients switching from tetrabenazine to deutetrabenazine is shown in below chert:   Current Tetrabenazine daily dosage Initial regimen of Deutetrabenazine 12.5 mg 6 mg once daily 25 mg 6 mg once daily 37.5 mg 9 mg once daily 50 mg 12 mg once daily 62.5 mg 15 mg once daily 75 mg 18 mg once daily 87.5 mg 21 mg once daily 100 mg 24 mg once daily After patients are switched to deutetrabenazine, the dose may be adjusted at weekly intervals.

Side effects

Most common adverse reactions (>8%) of deutetrabenzine’s are somnolence, diarrhea, dry mouth, and fatigue.

Precautions and warnings

Patients may experience Neuroleptic Malignant Syndrome (discontinue deutetrabenazine if this occurs), Akathisia, agitation, restlessness, and Parkinsonism (reduce the daily dose of deutetrabenazine or discontinue if this occurs) and Sedation/somnolence.

Pregnancy and lactation

There are no adequate data on the developmental risk associated with the use of deutetrabenazine in pregnant women. There are no data on the presence of deutetrabenazine or its metabolites in human milk, the effects on the breastfed infant, or the effects of the drug on milk production.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250